Theraly Pharmaceuticals theraly.com


Public list: Pharma Startups (6570) Cancer Therapeutics (1180)

Theraly is a product focused pharmaceutical company with a goal to efficiently generate medically important, stable, and long-acting therapies. Theraly enables products using its proprietary platform technology (4G-PEG) that can empower short-acting peptides and proteins by increasing their half-lives while maintaining potency. The company's lead program: TLY012, (a recombinant human protein) is a preclinical stage product in development for organ fibrosis. TLY012, has shown therapeutic efficacy...Show all

Theraly is a product focused pharmaceutical company with a goal to efficiently generate medically important, stable, and long-acting therapies. Theraly enables products using its proprietary platform technology (4G-PEG) that can empower short-acting ...Show all

Company (Alive / Active)

Phone:

Fax:



Baltimore,
Maryland, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Theraly Pharmaceuticals $0.8M Mar 21, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Theraly Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Maryland Technology Development CorporationPublic-Private PartnershipColumbia, Maryland, United StatesSeed - II, Seed
Undisclosed InvestorsOtherDebt
See all 2 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.